Cardiol Therapeutics Inc. (CRDL) Ownership
CRDL ownership summary
as of October 17, 2026- Institutions
- 26.4% of shares outstanding
- Insiders
- 2.27% of shares outstanding
- Shares outstanding
- 121.5M
- Float
- 92.0M shares available to trade
- Short interest
- 2.59% 3.1M shares short
- Days to cover
- 2.51 short interest down 7.3% vs prior month
- Institutions 26.38%
- Insiders 2.27%
- Other investors 71.34%
CRDL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Mmcap International Inc. Spc | 12.84% | 15.6M | $17.2M | +246,243 (+1.6%) | June 30, 2026 |
| 2 | Tejara Capital Ltd | 4.21% | 5.1M | $5.6M | −16,300 (−0.3%) | June 30, 2026 |
| 3 | Ikarian Capital, LLC | 2.74% | 3.3M | $3.7M | +600,000 (+22.0%) | June 30, 2026 |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | 0.80% | 976K | $1.1M | +180,840 (+22.8%) | June 30, 2026 |
| 5 | Citadel Advisors Llc | 0.66% | 797K | $876,182 | −23,375 (−2.9%) | June 30, 2026 |
| 6 | Renaissance Technologies Corp | 0.64% | 773K | $850,121 | +543,031 (+236.3%) | June 30, 2026 |
| 7 | Two Sigma Investments LLC | 0.61% | 747K | $821,631 | +212,726 (+39.8%) | June 30, 2026 |
| 8 | INTEGRITY ALLIANCE, LLC. | 0.32% | 388K | $427,341 | −76,533 (−16.5%) | June 30, 2026 |
| 9 | Morgan Stanley - Brokerage Accounts | 0.29% | 355K | $390,533 | +104,609 (+41.8%) | June 30, 2026 |
| 10 | The Goldman Sachs Group Inc | 0.27% | 334K | $367,290 | +1,500 (+0.5%) | June 30, 2026 |
| 11 | We Are One Seven, LLC | 0.08% | 100K | $110,000 | — | June 30, 2026 |
| 12 | 1832 Asset Management L.P | 0.08% | 100K | $110,000 | — | June 30, 2026 |
| 13 | Summit Financial LLC | 0.08% | 99K | $109,020 | −4,950 (−4.8%) | June 30, 2026 |
| 14 | Jane Street Group LLC | 0.04% | 53K | $58,758 | −73,541 (−57.9%) | June 30, 2026 |
| 15 | JPMorgan Chase & Co | 0.04% | 48K | $52,885 | — | June 30, 2026 |
| 16 | HRT FINANCIAL LLC | 0.04% | 47K | $51,897 | +47,179 (0.0%) | June 30, 2026 |
| 17 | Acadian Asset Management LLC | 0.04% | 44K | $48,681 | +44,255 (0.0%) | June 30, 2026 |
| 18 | Geode Capital Management, LLC | 0.03% | 42K | $46,416 | −10,239 (−19.5%) | June 30, 2026 |
| 19 | Marble Harbor Investment Counsel, LLC | 0.03% | 40K | $43,890 | — | June 30, 2026 |
| 20 | Boyer Financial Services, Inc. | 0.03% | 34K | $37,510 | +11,000 (+47.6%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 2.0M shares and 6 cut 205K.
CRDL top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | State Street® SPDR® S&P® Intl Sm Cp ETF | 0.08% | 100K | $110,000 | — | September 30, 2026 |
| 2 | Fidelity Nasdaq Composite Index | 0.02% | 18K | $20,314 | −42,196 (−69.6%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CRDL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CRDL
Institutional investors own 26.4% of Cardiol Therapeutics's shares and insiders 2.27%. The largest holder is Mmcap International Inc. Spc with 12.84% of the shares (15.6M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 6 reduced their stake in the latest filings. Short interest is 2.59% of the float, or 2.51 days of average trading volume. The share count rose 341.5% since 2017.
Related: CRDL analyst forecast, CRDL key metrics. See the CRDL stock overview for the latest quote and news.
CRDL ownership FAQ
Who owns the most Cardiol Therapeutics stock?
The largest shareholders of Cardiol Therapeutics are Mmcap International Inc. Spc (12.84%), Tejara Capital Ltd (4.21%), Ikarian Capital, LLC (2.74%), BOOTHBAY FUND MANAGEMENT, LLC (0.80%), Citadel Advisors Llc (0.66%).
What percentage of Cardiol Therapeutics is owned by institutions?
Institutions hold 26.4% of Cardiol Therapeutics's shares outstanding; insiders hold 2.27%.
Which funds own Cardiol Therapeutics?
The largest fund holders of Cardiol Therapeutics are State Street® SPDR® S&P® Intl Sm Cp ETF (0.08%), Fidelity Nasdaq Composite Index (0.02%).
What is Cardiol Therapeutics's short interest?
3.1M shares of Cardiol Therapeutics were sold short, 2.59% of the float; at the average daily volume it would take 2.51 days to cover.
How many shares of Cardiol Therapeutics are outstanding?
Cardiol Therapeutics has 121.5M shares outstanding, of which 92.0M are in the public float.